Aidarex Recalls Ferrous Sulfate Tablets Due to Foreign Material Presence
Aidarex Pharmaceuticals LLC is recalling 450 bottles of Ferrous Sulfate 325 MG tablets distributed in Florida because foreign tablets or capsules were found in the product.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 1/5 (Low).
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which by definition is unlikely to cause adverse health consequences, fitting the 'Low' severity criteria for minor or theoretical risks.
Plain-English summary
Aidarex Pharmaceuticals LLC is recalling 450 bottles of Ferrous Sulfate 325 MG tablets (NDC 33261-0715-00) due to the presence of foreign tablets or capsules. The affected product was distributed to Florida. The recall includes two specific batch IDs: 57909-1 with an expiration date of 04/30/2019, and 57909-2 with an expiration date of 06/30/2019.
The U.S. Food and Drug Administration has classified this recall as Class III, indicating that use of or exposure to the violative product is not likely to cause adverse health consequences. The primary hazard identified is the physical presence of foreign tablets or capsules within the product packaging.
Consumers who have purchased this product should check their inventory for the specific NDC and batch IDs listed above. If the product matches the recalled description, consumers should stop using it and contact their pharmacist or the recalling firm for instructions on return or disposal.
The recalled product
- Product
- Ferrous Sulfate 325 MG tablet; NDC 33261-0715-00
- Manufacturer
- Aidarex Pharmaceuticals LLC
- Category
- Drug — Oral Solid Dosage
- Hazard
- Affected units
- 450
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- NDC 33261-0715-00 Batch ID: 57909-1
- exp. date 04/30/2019 57909-2
- exp. date 06/30/2019
Distribution
Distributed in 1 state:
Related recalls
Same manufacturer · Aidarex Pharmaceuticals LLC
See all →- LowAidarex Recalls Enalapril Maleate 2.5mg Due to Stability Issues
FDA (Drugs) · 2018-08-01
- ModerateAidarex Recalls Enalapril Maleate Due to Out-of-Specification Degradation Product
FDA (Drugs) · 2018-08-01
- LowAidarex Recalls Enalapril Maleate Due to Out-of-Specification Degradation Product
FDA (Drugs) · 2018-08-01
- ModerateAidarex Recalls Enalapril Maleate Tablets Due to Impurity Failures
FDA (Drugs) · 2017-11-01
- LowAidarex Recalls Phentermine Capsules Due to Impurity Test Failures
FDA (Drugs) · 2017-09-20
Same hazard · foreign object
See all →- ModerateMezzetta Golden Greek Peperoncini Recalled for Potential Mouse Contamination
FDA (Food) · 2026-10-14
- SevereUnited and Good & Gather Light Brown Sugar Recalled for Wheat Contamination
FDA (Food) · 2026-09-30
- SevereBaxter Recalls Dextrose Injection Bags Due to Stainless Steel Particulate Matter
FDA (Drugs) · 2026-09-16
- ModerateBionpharma Recalls Doxylamine Succinate Tablets Due to Foreign Material Presence
FDA (Drugs) · 2026-09-09
- SevereTeva Recalls Trazodone Hydrochloride Tablets Due to Foreign Material
FDA (Drugs) · 2026-09-09
Similar recalls
- ModerateAidapak Recalls Ferrous Sulfate Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- LowFerrous Sulfate Tablets Recalled for Foreign Material Contamination
FDA (Food) · 2013-04-17
- SevereAurobindo Recalls Famotidine 40mg Tablets Due to Foreign Tablet Presence
FDA (Drugs) · 2021-03-10
- ModerateFDA Recalls Ferrous Sulfate Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- HighTrazodone tablets recalled over the presence of foreign tablets
FDA (Drugs) · 2026-02-11
- LowNostrum Recalls Calcium Acetate Capsules Due to Foreign Material Presence
FDA (Drugs) · 2018-02-28